Transcranial Magnetic Stimulation (TMS)

Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique used to treat depression and other psychiatric conditions. By generating magnetic fields, TMS stimulates specific brain regions, particularly the prefrontal cortex, which is often underactive in depression.

TMS is typically administered in outpatient settings, with sessions lasting about 20-40 minutes over several weeks. Unlike electroconvulsive therapy (ECT), TMS does not require anesthesia and has fewer cognitive side effects. Patients usually experience only mild discomfort at the treatment site.

Clinical studies have demonstrated TMS's efficacy in alleviating symptoms of treatment-resistant depression, with many patients achieving significant improvement or remission. The mechanism involves modulating neural activity and enhancing synaptic plasticity, contributing to better mood regulation.

While TMS is generally well-tolerated, some patients may experience headaches or scalp discomfort. As research progresses, TMS is expanding its applications, offering a promising, evidence-based option for individuals unresponsive to conventional treatments.

    Related Conference of Transcranial Magnetic Stimulation (TMS)

    September 14-15, 2026

    20th International Conference on Mental Health & Psychiatry

    Barcelona, Spain
    September 14-15, 2026

    18th International Conference on Addiction & Psychiatry

    Barcelona, Spain
    September 23-24, 2026

    6th Annual Congress on Mental Health

    Amsterdam, Netherlands
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France
    October 26-27, 2026

    International Congress on Cognitive Psychotherapy

    Amsterdam, Netherlands
    October 26-27, 2026

    6th Annual Psychiatrists and Psychologists Meet

    Amsterdam, Netherlands

    Transcranial Magnetic Stimulation (TMS) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in